SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-24-026552
Filing Date
2024-02-22
Accepted
2024-02-22 16:29:57
Documents
1
Group Members
MICHAEL P. RUBINNORTHPOND VENTURES GP, LLCNORTHPOND VENTURES III GP, LLCNORTHPOND VENTURES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G tm246946d1_sc13g.htm SC 13G 120383
  Complete submission text file 0001104659-24-026552.txt   122176
Mailing Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814
Business Address 7500 OLD GEORGETOWN ROAD SUITE 800 BETHESDA MD 20814 (240) 800-1200
Northpond Ventures III, LP (Filed by) CIK: 0001972690 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Subject) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94441 | Film No.: 24665290
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)